Cosmax Group has expanded its microbiome research partnership with Mass General Brigham, a network of Harvard Medical School-affiliated teaching hospitals, as the Korean cosmetics company pushes beyond beauty products into health supplements and drug development. The two sides signed an agreement Oct. 13 at Massachusetts General Hospital in Boston to launch the second phase of their joint VIVA Project. Cosmax Group Chairman Lee Kyung-soo and MGB Chief Development Officer Mike McNally attended. R
Cosmax Group has expanded its microbiome research partnership with Mass General Brigham, a network of Harvard Medical School-affiliated teaching hospitals, as the Korean cosmetics company pushes beyond beauty products into health supplements and drug development. The two sides signed an agreement Oct. 13 at Massachusetts General Hospital in Boston to launch the second phase of their joint VIVA Project. Cosmax Group Chairman Lee Kyung-soo and MGB Chief Development Officer Mike McNally attended. RThis article was originally published by The Korea Herald.
Read Full Story on Source Site →
